News Conference News TCT 2013 EUROMAX: Prehospital Bivalirudin Reduces Bleeding in STEMI October 30, 2013
News Conference News ESC 2013 ESC Congress 2013: Mix of Trials with Potential to Reshape Practice September 09, 2013
News Conference News ESC 2013 Cooling, PCI Improves Long-term Outcomes for Cardiac Arrest Survivors Yael L. Maxwell September 04, 2013
News Conference News ESC 2013 Novel Anticoagulant Edoxaban Surpasses Warfarin Across Spectrum of VTE Patients Caitlin E. Cox September 02, 2013
News Conference News ESC 2013 TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS Caitlin E. Cox September 01, 2013
News Conference News EuroPCR 2013 EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges Caitlin E. Cox May 29, 2013
News Conference News EuroPCR 2013 Registry Questions Superiority of Bivalirudin Over Heparin Alone in NSTE-ACS Yael L. Maxwell May 23, 2013
News Conference News ACC 2013 ULTIMA: Ultrasound Accelerated Thrombolysis Shows Promise for Pulmonary Embolism L.A. McKeown March 08, 2013
News Conference News TCT 2012 STEMI-RADIAL Radial PCI Bests Femoral in STEMI Patients Caitlin E. Cox October 26, 2012
News Conference News ESC 2012 Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis Caitlin E. Cox August 29, 2012
News Conference News ESC 2012 STEMI Patient Population Evolves Over 15 Years Yael L. Maxwell August 27, 2012
News Conference News ACC 2012 Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism L.A. McKeown March 26, 2012
News Conference News ACC 2012 Anti-inflammatory Lowers In-Stent Late Loss After BMS Implantation March 24, 2012
News Conference News Prasugrel Bests Double Clopidogrel Dose for STEMI Patients with High Residual Platelet Reactivity November 17, 2011
News Conference News ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients November 13, 2011
News Conference News BRAVO: Fewer Adverse Events with Bivalirudin vs. Heparin After Aortic Valvuloplasty November 07, 2011
News Conference News Stent Grafts Found Effective for SFA Patients with Moderate, Long Lesions November 06, 2011
News Conference News Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS September 02, 2011